Raymond James & Associates »

G1 Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.5M 803k 4.32
2023-12-31 $1.7M 566k 3.05
2023-09-30 $1.3M 926k 1.44
2023-06-30 $2.0M 792k 2.49
2023-03-31 $2.0M 747k 2.68
2022-12-31 $2.7M 499k 5.43
2022-09-30 $6.0M 480k 12.49
2022-06-30 $2.2M 438k 4.94
2022-03-31 $3.0M 398k 7.60
2021-12-31 $2.4M 231k 10.21
2021-09-30 $1.8M 135k 13.42
2021-06-30 $2.9M 133k 21.94
2021-03-31 $3.2M 134k 24.06
2020-12-31 $2.6M 145k 17.99
2020-09-30 $1.9M 165k 11.55
2020-06-30 $3.7M 153k 24.26
2020-03-31 $124k 11k 10.99
2019-12-31 $233k 8.8k 26.42